StopDown
VC fund

RMB Capitalworks

RMB Capitalworks took part in 2 disclosed rounds in Indian startups in 2026 (2 as lead), most often Growth rounds in Enterprise Software & IT; its latest was Biodeal Pharmaceuticals on 10 August 2026.

2Indian companies
2StopDown stories

About RMB Capitalworks

RMB Capitalworks has backed Indian startups that StopDown covered, listed below.

Deals in 2026

Deals in 2026
DateCompanyRoundAmountRoleCo-investorsStory
10 August 2026Biodeal PharmaceuticalsBiodeal Pharmaceuticalsgrowth₹385 croreLeadStory
10 March 2026MozarkSeries B$40MLeadInternational Finance Corporation, Kalaari CapitalStory

Stage and sector mix

Disclosed rounds RMB Capitalworks took part in, by stage and by sector.

Stage and sector mix
Stage20262025
Series B10
Growth10
Stage and sector mix
Sector20262025
Enterprise Software & IT10
Healthcare & Life Sciences10

Frequent co-investors

Frequent co-investors
InvestorRounds together
International Finance Corporation1
Kalaari Capital1

Indian portfolio

Showing 2

India-based companies only. Linked names have a StopDown page; the rest link up on their own as soon as we cover them.

RMB Capitalworks in the news

Questions about RMB Capitalworks

How many investments did RMB Capitalworks make in India in 2026?

StopDown has recorded 2 disclosed rounds in Indian startups with RMB Capitalworks in 2026 so far, 2 of them as lead. The latest was Biodeal Pharmaceuticals on 10 August 2026 (₹385 crore).

Which sectors does RMB Capitalworks invest in?

In the 2025 and 2026 rounds StopDown recorded, RMB Capitalworks invested most often in Enterprise Software & IT (1 round) and Healthcare & Life Sciences (1 round).

Does RMB Capitalworks lead rounds?

Yes. StopDown's records name RMB Capitalworks as lead or co-lead in 2 of the 2 rounds it took part in during 2025 and 2026, 2 of them in 2026.